Centre Hospitalier Universitaire De Bordeaux — Sponsor Intelligence | 27 EU Trials

Filter these 27 trials by condition, phase, country and more.

Open in Search →

27 Registered trials

14 Recruiting

7 Completed trials

1 Countries active

60 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III: 8 Phase II/III: 1 Phase II: 13 Phase I/II: 2 Phase III/IV: 2 Phase IV: 1

Oversight events:

2 temporary halts 1 unexpected event across 3 trials

View oversight register →

100%

7 of 7 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Apathy 1 Rectal cancer 1 Vitiligo 1 Metastatic renal cell carcinoma 1 HIV infection 1 Sternotomy 1 Cholangiocarcinoma 1 Skin dystrophy 1

Top IMPs

GALLIUM (68GA) CHLORIDE 3 GERMANIUM (68GE) CHLORIDE 3 (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE 2 CLOPIDOGREL 2 GALLIUM CITRATE GA-68 2 ADALIMUMAB 1 AMLODIPINE BESILATE 1 AMOXICILLIN, CLAVULANIC ACID 1 ANIFROLUMAB 1 ARGININE HYDROCHLORIDE, LYSINE HYDROCHLORIDE 1 AXITINIB 1 BARICITINIB 1

All trials

27 total

Phase 1/2 evaluating the addition of venetoclax to standard 3+7 and midostaurin induction treatment in patients with FLT3-mutated Acute Myel… Pending

2024-517130-17-00 Phase I/II 1 country VENETOCLAX
Efficacy and safety of circumcision alone on risk of febrile urinary tract infections in boys with posterior urethral valves: a prospective … Pending

2024-519166-48-01 Phase II 1 country AMOXICILLIN, CLAVULANIC ACID; CEFACLOR; SULFAMETHOXAZOLE, TRIMETHOPRIM
Echo-guided scalp blocks and incidence of postoperative pain in scheduled supratentorial intracranial surgery. Pending

2024-520320-28-00 Phase III/IV 1 country EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE; PARACETAMOL; ROPIVACAINE HYDROC…
Botulinum toxin injection after sternotomies to improve scar aspect and impact Pending

2025-521290-14-00 Phase III 1 country BOTULINUM TOXIN TYPE A
Staging of gastric cancers by PET-FAPI Pending

2025-524434-25-00 Phase II 1 country (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHY…
Multicentre study evaluating the efficacy of a 7-day course of doxycycline for the treatment of asymptomatic anal lymphogranuloma venereum S… Pending

2025-524978-42-00 Phase II 1 country DOXYCYCLINE MONOHYDRATE
FAPI-PET value for the initial screening of pancreatic and biliary cancers (FAPDIG Study) Recruiting

2024-517270-23-00 Phase II 1 country (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHY…
Combination of baricitinib and anti-TNF in rheumatoid arthritis Recruiting

2024-511442-39-00 Phase III 1 country ADALIMUMAB; BARICITINIB; ETANERCEPT
Contribution of PET/CT with Gallium 68 citrate (68Ga-PET/CT) for the diagnosis of prosthetic valve infective endocarditis - CiGal-EI-TEP Recruiting

2024-514331-24-00 Phase II 1 country GALLIUM CITRATE GA-68
Hypertension induced by intravenous administration of norepinephrine to improve the prognosis of patients with neurological deterioration in… Recruiting

2023-508704-37-00 Phase III 1 country NORADRENALINE TARTRATE
AntiPlatelet theraPy stratEgy followiNg left atrial appenDAGe closurE Recruiting

2024-515774-27-00 Phase IV 1 country CLOPIDOGREL; D,L-LYSINE ACETYLSALICYLATE
Phase III randomized, multicenter open label clinical trial to evaluate the efficacy of immunomodulatory therapy in case of psychiatric diso… Recruiting

2024-518259-49-00 Phase III 1 country RITUXIMAB
Efficacy and tolerability of the combination of anifrolumab (300 mg IV) and phototherapy versus phototherapy in adults with progressive viti… Recruiting

2024-512041-17-00 Phase II 1 country ANIFROLUMAB
Effectiveness of an Optimisation Strategy for Emergency Tracheal Intubation on postintubation Morbidity: A superiority cluster randomised co… Recruiting

2024-514913-37-00 Phase III/IV 1 country ROCURONIUM BROMIDE; SUGAMMADEX; SUXAMETHONIUM CHLORIDE
Preventive effect of Clopidogrel on the systemic sclerosis development risk Recruiting

2024-511005-39-00 Phase II/III 1 country CLOPIDOGREL
Benefit of positons emission tomography / 68Gallium citrate tomodensitometry for artificial hip and knee chronic infection diagnosis Recruiting

2024-515781-13-00 Phase II 1 country GALLIUM CITRATE GA-68
Intra-arterial hepatic (IAH) infusion of radiolabelled somatostatin analogs in GEP-NET patients with dominant liver metastases Recruiting

2024-514785-39-00 Phase II 1 country AMLODIPINE BESILATE; ARGININE HYDROCHLORIDE, LYSINE HYDROCHLORIDE; EDOTREOTIDE; …
In vivo involvement of the cholinergic and dopaminergic systems in the pathophysiology of apathy. ADACHOL. Recruiting

2024-518721-15-00 Phase III 1 country FLUORODOPA (18F); FLUOROETHOXYBENZOVESAMICOL F-18
PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF EARLY OXYBUTININ TREATMENT FOR BOYS WITH POSTERIOR URETHRAL VALVES - PRETIPUV - Recruiting

2024-515844-22-00 Phase II 1 country OXYBUTYNIN
TRAnexamic Acid for Preventing blood loss following a cesarean delivery in women with placenta pREVIA: a multicenter randomised, double blin… Recruiting

2024-515276-12-00 Phase III 1 country
Immune response to the recombinant Zoster Vaccine in people living with HIV over 50 years of age compared to non-HIV age- and gender-matched… Ended

2023-504482-23-00 Phase II 1 country RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E
Treatment pause versus treatment continuation in good or intermediate risk with only one adverse prognostic factor in mRCC patients that has… Ended

2024-514644-93-00 Phase III 1 country AXITINIB; CABOZANTINIB; LENVATINIB; NIVOLUMAB; PEMBROLIZUMAB
Methotrexate and Metformin in rheumatoid arthritis patients. Ended

2024-511033-35-00 Phase II 1 country METFORMIN HYDROCHLORIDE
A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as pre-operative treatment f… Ended

2024-514705-62-00 Phase III 1 country CAPECITABINE; FLUOROURACIL; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; LEVOLEUCOVORIN;…

Showing 1–24 of 27 trials

← All sponsors A–Z